Dupilumab as a novel steroid-sparing treatment for hypereosinophilic syndrome

Authors: Xiaoman Du, MD, Yudi Chen, MD, Jianmin Chang, MD, Xuelin Sun, MD, PhD, Yue Zhang, MS, Meng Zhang, BM, Marcus Maurer, MD, PhD, Yanming Li, MD, Zuotao Zhao, MD, PhD, Xunliang Tong, MD, PhD

Source: JAAD Case Reports, Vol 29, Iss , Pp 106-109 (2022)

Subject Terms: eosinophils, pulmonary, skin, therapy, type 2 inflammation, Dermatology, RL1-803

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352512622001448; https://doaj.org/toc/2352-5126

Access URL: https://doaj.org/article/7e64d60b09964bad8b37dea7df2f7c84

Expert consensus on the use of omalizumab in chronic urticaria in China

Authors: Zuotao Zhao, MD, PhD, Tao Cai, MD, Hong Chen, MD, Liuqing Chen, MD, Yudi Chen, MD, Xiang Gao, MD, Xinghua Gao, MD, Songmei Geng, MD, Yinshi Guo, MD, Fei Hao, MD, Guodong Hao, MM, Yan Hu, MD, Hongzhong Jin, MD, Zhehu Jin, MD, Chengxin Li, MD, Haili Li, MD, Jie Li, MD, Yanming Li, MD, Yunsheng Liang, MD, Guanghui Liu, MD, Qiang Liu, MD, Hai Long, MD, Lin Ma, MD, Yuanyuan Shang, MM, Yuxin Song, MB, Zhiqiang Song, MD, Xiangyang Su, MD, Haijing Sui, MD, Qing Sun, MD, Yuemei Sun, MB, Jianping Tang, MD, Xunliang Tong, MD, Huiying Wang, MD, Gang Wang, MD, Lianglu Wang, MD, Siqin Wang, MB, Li Xiang, MD, Ting Xiao, MD, Zhiqiang Xie, MD., Leping Ye, MD, Yongmei Yu, MM, Chunlei Zhang, MD, PhD, Litao Zhang, MD, Shuchen Zhang, MD, PhD, Rui Zheng, MD, Lili Zhi, MM, Wei Zhou, MD, Ying Zou, MD, Marcus Maurer, MD

Source: World Allergy Organization Journal, Vol 14, Iss 11, Pp 100610- (2021)

Subject Terms: Chronic spontaneous urticaria, Chronic inducible urticaria, Treatment algorithm, Omalizumab, China, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1939455121001046; https://doaj.org/toc/1939-4551

Access URL: https://doaj.org/article/9875079723964e719a0bcd96761f2778